122 related articles for article (PubMed ID: 3328922)
1. [Pathogenesis and immunology of lactic dehydrogenase virus (LDV)].
Inada T; Yamazaki S
Uirusu; 1987 Dec; 37(2):193-210. PubMed ID: 3328922
[No Abstract] [Full Text] [Related]
2. Clearance of lactate dehydrogenase by SJL/J mice infected with lactate dehydrogenase-elevating virus.
Brinton MA; Plagemann PG
J Reticuloendothel Soc; 1983 May; 33(5):391-400. PubMed ID: 6842466
[TBL] [Abstract][Full Text] [Related]
3. Enhanced clearance of lactic dehydrogenase-5 in severe combined immunodeficiency (SCID) mice: effect of lactic dehydrogenase virus on enzyme clearance.
Hayashi T; Ozaki M; Mori I; Saito M; Itoh T; Yamamoto H
Int J Exp Pathol; 1992 Apr; 73(2):173-81. PubMed ID: 1571277
[TBL] [Abstract][Full Text] [Related]
4. The pathogenesis of lactate dehydrogenase elevating virus in mice.
Stauber E; Burger D; Piper R
J Comp Pathol; 1975 Apr; 85(2):171-83. PubMed ID: 1141457
[No Abstract] [Full Text] [Related]
5. Monoclonal antibody protection from age-dependent poliomyelitis: implications regarding the pathogenesis of lactate dehydrogenase-elevating virus.
Harty JT; Plagemann PG
J Virol; 1990 Dec; 64(12):6257-62. PubMed ID: 2243393
[TBL] [Abstract][Full Text] [Related]
6. Persistent infection of mice by lactate dehydrogenase-elevating virus: effects of immunosuppression on virus replication and antiviral immune responses.
Onyekaba CO; Harty JT; Even C; Hu BG; Plagemann PG
Virus Res; 1989 Dec; 14(4):297-315. PubMed ID: 2623944
[TBL] [Abstract][Full Text] [Related]
7. Effect of prostaglandin E2 on plasma lactic dehydrogenase activity in (NZB x NZW)F1 mice with a chronic infection of lactic dehydrogenase virus.
Hayashi T
J Comp Pathol; 1992 Jul; 107(1):41-8. PubMed ID: 1430347
[TBL] [Abstract][Full Text] [Related]
8. Identification of lactate dehydrogenase-elevating virus as the etiological agent of genetically restricted, age-dependent polioencephalomyelitis of mice.
Martinez D; Brinton MA; Tachovsky TG; Phelps AH
Infect Immun; 1980 Mar; 27(3):979-87. PubMed ID: 7380559
[TBL] [Abstract][Full Text] [Related]
9. Protection of C58 mice from lactate dehydrogenase-elevating virus-induced motor neuron disease by non-neutralizing antiviral antibodies without interference with virus replication.
Harty JT; Chan SP; Contag CH; Plagemann PG
J Neuroimmunol; 1987 Jun; 15(2):195-206. PubMed ID: 3034974
[TBL] [Abstract][Full Text] [Related]
10. Neutralization and sensitization of lactate dehydrogenase-elevating virus with monoclonal antibodies.
Coutelier JP; Van Snick J
J Gen Virol; 1988 Aug; 69 ( Pt 8)():2097-100. PubMed ID: 3404124
[TBL] [Abstract][Full Text] [Related]
11. Immune responses in mice infected with lactic dehydrogenase virus. III. Antibody response to a T-dependent and a T-independent antigen during acute and chronic LDV infection.
Michaelides MC; Simms ES
Cell Immunol; 1980 Mar; 50(2):253-60. PubMed ID: 6986993
[No Abstract] [Full Text] [Related]
12. Regulation of maternal-fetal virus transmission in immunologically reconstituted SCID mice infected with lactate dehydrogenase-elevating virus.
Broen JB; Bradley DS; Powell KM; Cafruny WA
Viral Immunol; 1992; 5(2):133-40. PubMed ID: 1616584
[TBL] [Abstract][Full Text] [Related]
13. Delayed foreign-body tumorigenesis in mice infected with lactate dehydrogenase-elevating virus: Brief communication.
Brinton-Darnell M; Brand I
J Natl Cancer Inst; 1977 Sep; 59(3):1027-9. PubMed ID: 330868
[TBL] [Abstract][Full Text] [Related]
14. A tumor-associated lactic dehydrogenase virus suppresses the host resistance to infection with Listeria monocytogenes.
Isakov N; Segal S
Immunobiology; 1983 May; 164(5):402-16. PubMed ID: 6873999
[TBL] [Abstract][Full Text] [Related]
15. Lactic dehydrogenase virus.
Rowson KE; Mahy BW
Virol Monogr; 1975; (13):1-121. PubMed ID: 1154649
[No Abstract] [Full Text] [Related]
16. A new host species for lactic dehydrogenase virus.
Rowson KE
Experientia; 1980 Sep; 36(9):1066-7. PubMed ID: 7418841
[TBL] [Abstract][Full Text] [Related]
17. Isolation of Clq-binding virus-antibody immune complexes from lactic dehydrogenase virus (LDV)-infected mice.
McDonald TL
Immunology; 1982 Feb; 45(2):365-70. PubMed ID: 6977483
[TBL] [Abstract][Full Text] [Related]
18. Characteristics of monoclonal antibodies to the lactate dehydrogenase-elevating virus.
Harty JT; Chan SP; Plagemann PG
Intervirology; 1987; 27(1):53-60. PubMed ID: 3610572
[TBL] [Abstract][Full Text] [Related]
19. Correlation of extracts obtained by high efficiency gel chromatography of lactic dehydrogenase virus infected mouse serum and cytosol from human tumors using leukocyte adherence inhibition assay.
Jandová A; Mejsnarová B; Motycka K; Coupek J; Sanitrák J; Heyberger K; Pezlarová J
Neoplasma; 1979; 26(3):261-6. PubMed ID: 394008
[TBL] [Abstract][Full Text] [Related]
20. Antibody classes and subclasses in circulating immune complexes isolated from mice infected with lactic dehydrogenase virus.
McDonald TL; Donnelly T; Weber A; Quenette L
Immunology; 1983 Mar; 48(3):511-7. PubMed ID: 6826202
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
